- ¥1tn
- ¥1tn
- ¥480bn
- 84
- 26
- 91
- 78
Annual balance sheet for SCSK, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 112,107 | 108,988 | 122,333 | 121,624 | 149,370 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 80,561 | 83,135 | 84,363 | 97,362 | 100,491 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 213,891 | 212,524 | 230,055 | 244,099 | 272,834 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 87,645 | 106,698 | 113,287 | 120,993 | 113,915 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 362,241 | 380,399 | 407,609 | 435,469 | 471,400 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 101,559 | 97,820 | 101,175 | 108,367 | 105,535 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 162,194 | 153,525 | 160,688 | 163,559 | 169,145 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 200,047 | 226,874 | 246,921 | 271,910 | 302,255 |
Total Liabilities & Shareholders' Equity | 362,241 | 380,399 | 407,609 | 435,469 | 471,400 |
Total Common Shares Outstanding |